% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • rakanobo rakanobo Oct 10, 2013 1:06 PM Flag

    8 Reasons to Invest In GALE

    1) NeuVax decreased recurrence by nearly 80% in targeted group.
    2) NeuVax's targeted group is twice the size of Herceptin's group
    3) Herceptin did revenue of $7 billion in last 12 months
    4) GALE has market cap of $200 million

    5) INSY has created gains of 500% in the last year with the success of its fentanyl product Subsys
    6) INSY product is near identical to Abstral, but Abstral works faster
    7) GALE could triple on success from Abstral

    8) GALE worth $600million on success of Abstral and $15 billion on success of NeuVax.

    The End!

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.7161+0.0450(+6.71%)3:18 PMEST